TCW Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

TCW Group’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-347,381	Closed	-$31.2M	–	321
2020 Q1	$31.2M	Sell	347,381 -64,004	-16%	-$5.75M	0.43%	61
2019 Q4	$44.5M	Sell	411,385 -38,197	-8%	-$4.13M	0.49%	65
2019 Q3	$44M	Sell	449,582 -57,717	-11%	-$5.65M	0.5%	64
2019 Q2	$66.4M	Sell	507,299 -9,376	-2%	-$1.23M	0.71%	52
2019 Q1	$69.8M	Sell	516,675 -286	-0.1%	-$38.7K	0.67%	60
2018 Q4	$50.3M	Sell	516,961 -50,950	-9%	-$4.96M	0.52%	64
2018 Q3	$78.9M	Sell	567,911 -2,821	-0.5%	-$392K	0.65%	58
2018 Q2	$70.9M	Sell	570,732 -26,553	-4%	-$3.3M	0.57%	69
2018 Q1	$66.6M	Sell	597,285 -53,475	-8%	-$5.96M	0.54%	69
2017 Q4	$77.8M	Sell	650,760 -57,361	-8%	-$6.86M	0.63%	61
2017 Q3	$99.3M	Sell	708,121 -21,146	-3%	-$2.97M	0.79%	52
2017 Q2	$88.7M	Sell	729,267 -24,627	-3%	-$3M	0.74%	52
2017 Q1	$91.4M	Sell	753,894 -329,534	-30%	-$40M	0.76%	56
2016 Q4	$133M	Sell	1,083,428 -40,397	-4%	-$4.94M	1%	39
2016 Q3	$138M	Sell	1,123,825 -25,039	-2%	-$3.07M	1.05%	33
2016 Q2	$134M	Buy	1,148,864 +39,690	+4%	+$4.63M	1.01%	35
2016 Q1	$154M	Sell	1,109,174 -227	-0%	-$31.6K	1.13%	26
2015 Q4	$212M	Buy	1,109,401 +4,457	+0.4%	+$850K	1.52%	13
2015 Q3	$173M	Buy	1,104,944 +54,345	+5%	+$8.5M	1.24%	21
2015 Q2	$190M	Sell	1,050,599 -49,648	-5%	-$8.97M	1.22%	21
2015 Q1	$191M	Buy	1,100,247 +372,822	+51%	+$64.6M	0.92%	31
2014 Q4	$135M	Buy	727,425 +621,495	+587%	+$115M	0.56%	64
2014 Q3	$17.6M	Buy	105,930 +2,150	+2%	+$357K	0.07%	223
2014 Q2	$16.2M	Buy	103,780 +800	+0.8%	+$125K	0.07%	241
2014 Q1	$15.7M	Sell	102,980 -3,119	-3%	-$474K	0.07%	238
2013 Q4	$14.1M	Buy	106,099 +629	+0.6%	+$83.7K	0.06%	263
2013 Q3	$12.3M	Buy	105,470 +800	+0.8%	+$92.9K	0.06%	269
2013 Q2	$9.65M	Buy	+104,670	New	+$9.65M	0.05%	310